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Abstract
In 2003, the International Patient Decision Aid Standards (IPDAS) Collaboration was established to enhance the
quality and effectiveness of patient decision aids by establishing an evidence-informed framework for improving
their content, development, implementation, and evaluation. Over this 10 year period, the Collaboration has
established: a) the background document on 12 core dimensions to inform the original modified Delphi process to
establish the IPDAS checklist (74 items); b) the valid and reliable IPDAS instrument (47 items); and c) the IPDAS
qualifying (6 items), certifying (6 items + 4 items for screening), and quality criteria (28 items). The objective of this
paper is to describe the evolution of the IPDAS Collaboration and discuss the standardized process used to update
the background documents on the theoretical rationales, evidence and emerging issues underlying the 12 core
dimensions for assessing the quality of patient decision aids.
Background
Patient decision aids
Patient decision aids are tools designed to help people
participate in decision making about health care options,
with the goal of promoting deliberation between patients,
health care providers, and others about those options.
They provide information about the options, and help
patients to construct, clarify, and communicate the per-
sonal values they associate with the different features of
the options. Patient decision aids do not advise people to
choose one option over another, nor are they meant to
replace practitioner consultation. Instead, they provide
structured guidance in the steps of decision making and
to prepare patients to make informed, values-based deci-
sions with their practitioner [1-3].
The International Patient Decision Aid Standards (IPDAS)
Collaboration
The International Patient Decision Aid Standards (IPDAS)
Collaboration is a world-wide group of researchers, practi-
tioners, and stakeholders who are interested in the design
and use of patient decision aids. It was established in Sep-
tember, 2003, at the International Shared Decision Making
(ISDM) Conference in Swansea, Wales. (“Shared Decision
Making”, or SDM, is defined as an approach where clini-
cians and patients make decisions together using the best
available evidence. Shared decision making emphasizes
respect for patient autonomy and promotes patient
engagement, by encouraging patients to think about the
available screening or treatment options and the likely
benefits and harms of each option in preparation for com-
municating their preferences and selecting the best course
of action for them. Patient decision aids are often used
during this process of shared decision making [4,5].)
The overall purpose of the IPDAS Collaboration is to
enhance the quality and effectiveness of patient decision
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aids, by establishing an evidence-informed framework
for improving their content, development, implementa-
tion, and evaluation. As its initial task, in 2003, the IPDAS
Collaboration undertook the identification of internation-
ally-approved set of standards that could be used by indi-
viduals and organizations to guide: a) the development
new patient decision aids; as well as b) the evaluation of
the quality of existing patient decision aids.
Why are standards needed?
At the 2003 ISDM Conference, the IPDAS Collaboration
agreed that a problem may be emerging. Hundreds of
patient decision aids were available or were being devel-
oped by many different individuals and groups around
the world. The growth of the internet and mobile tech-
nologies provided a tremendous opportunity for dissemi-
nation of patient decision aids. However, people may
have difficulty knowing whether or not a patient decision
aid is a source of reliable health information that can
help in decision making. Therefore, the need for a set of
standard criteria was identified as a mechanism to guide
quality appraisal of patient decision aids by a wide variety
of individuals and organizations that use and/or develop
patient decision aids.
Processes and products
2003-2006: Developing the IPDAS checklist
The IPDAS Collaboration’s Steering Group led this initial
task; see Elwyn et al. for the procedural details [6]. To
begin, the Steering Group sought opinions from the parti-
cipants in the 2003 ISDM Meeting and from the shared
decision making electronic listserve (“SMDM-L”) about
which broad evaluative dimensions should be used for
assessing the quality of patient decision aids. Twelve such
quality dimensions were identified.
From there, 12 workgroups were formed. Each work-
group was assigned one of the quality dimensions and
was given the following tasks: 1) offer a definition of
that quality dimension; 2) outline the theoretical ratio-
nale for considering that dimension as an important
aspect of the quality of patient decision aids; 3) provide
a summary of the relevant evidence base underlying that
quality dimension; and 4) list the relevant theoretical
and empirical references for that dimension. The IPDAS
Collaboration’s resulting 12-chapter “Original Back-
ground Document” was published in 2005; it can be
found at the IPDAS collaboration website (http://ipdas.
ohri.ca/resources.html). Of the 12 chapters, three were
subsequently published as peer-reviewed manuscripts
focused on providing information, measuring decision
quality, and communicating probabilities [7-9].
The Steering Group envisioned a checklist of standard
criteria reflecting these 12 key evaluative dimensions.
Therefore, during this initial phase, each workgroup was
also asked to propose and draft the specific evaluative
criteria that they thought should be used to gauge
whether or not a patient decision aid satisfactorily
addressed their quality dimension.
Next, a modified Delphi consensus voting process was
used to select a final set of criteria for the checklist. Five
groups of stakeholders participated in the Delphi voting
process: patients, practitioners, developers, researchers,
and policy makers or payers. Each voter was provided
with a series of 12 half-page summaries on the quality
dimensions (e.g. theoretical rational, evidence) plus the
dimension specific criteria for voting. For more detailed
information on the quality dimensions, the IPDAS
Collaboration’s 12-chapter 2005 Original Background
Document was provided. Each voter was asked to rate
the importance of each criterion on a 9-point scale.
More than 100 stakeholders from 14 countries partici-
pated in the first phase of voting; in the second phase,
stakeholders were provided summary ratings for each
criterion from the first round’s results and asked to re-
rate their importance on the 9-point scale. Criteria with
median voting scores of 7 or higher on the 9-point scale
were retained in the final IPDAS checklist. More details
of the voting process and results can be found at the
IPDAS website (http://ipdas.ohri.ca).
The final IPDAS Checklist included 74 criteria from
11 of the 12 quality dimensions. Criteria from the qual-
ity dimension about “addressing patient stories” did not
reach the median score threshold, largely due to uncer-
tainty about the potential benefits and biasing effects of
stories in patient decision aids. However, these criteria
were added to the checklist as additional criteria to con-
sider when stories are used in patient decision aids. A
shorter version of the checklist, limited to those criteria
receiving ratings of 9, is used to rate the patient decision
aids that are included in the Ottawa A to Z Decision
Aid Inventory (http://decisionaid.ohri.ca).
2006-2009: Developing the IPDAS instrument
The IPDAS Checklist provides broad assessments of the
quality of a patient decision aid across the 12 quality
dimensions. But it does not provide precise, quantitative
judgments of the decision aid’s quality at criterion (item),
dimension, or global levels. To address this concern, the
IPDAS Collaboration undertook a project to develop,
validate, and report the inter-rater reliability of a mea-
surement instrument designed for quantitatively asses-
sing the quality of patient decision aids—that is, the
IPDAS instrument or IPDASi [10].
Criterion-items on the original IPDAS Checklist were
refined, items were removed if they did not apply to
all decision aids, and the items from the “balancing
the presentation of options” dimension were combined
with those from the “providing information” dimension.
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A 4-point rating scale was adopted for each criterion-
item, with the following response options: strongly
agree, agree, disagree, and strongly disagree. The refine-
ment and confirmation steps yielded 47 items represent-
ing 10 dimensions. From there, a validation study was
conducted in which the inter-rater reliability of
responses on these 47 criterion-items was assessed,
using 15 patient decision aids from major producers
plus 66 decision aids randomly selected from the
Cochrane inventory that is maintained by the Ottawa
Patient Decision Aids Group. A short version of the
IPDASi was produced, comprising 19 items across 8 of
the original dimensions from the checklist [10].
2009-2013: Agreeing on minimal standards for certifying
patient decision aids
Recognizing that certification of patient decision aids is
becoming a priority of health systems in several coun-
tries, the IPDAS Collaboration undertook the challenge
of identifying a minimal set of standards that could be
used to certify the quality of a patient decision aid [11].
A modified Delphi process was used to assess each
IPDASi criterion on the basis of the potential for risk or
harmful bias to the patient’s decision making if the cri-
terion were not present or of low quality in a decision
aid. One hundred and one individuals with experience
in the field of shared decision making and decision aids
voted in the first round, and 87 voted in a second
round. The initial set of 47 items from the IPDASi was
reduced to 44 items.
A panel of 11 experts was established to reach consen-
sus on minimal criteria based on: a) ratings for the 47
IPDASi items from a modified 2-stage Delphi process;
b) qualitative feedback from voters on each of the 47
items in this Delphi process; c) original IPDAS consen-
sus process scores; and d) feedback from 4 trained
raters. The expert panel grouped the criteria-items into
three broad categories: qualifying criteria, certification
criteria, and quality criteria. Six “qualifying criteria”
were identified as essential for a tool to be considered a
patient decision aid; a tool would not be considered a
patient decision aid unless all criteria were met. Six
additional criteria were identified as “certification cri-
teria” plus an extra 4 certifying criteria if the patient
decision aid is about screening. These criteria were
scored on a 1-4 scale (1= strongly disagree and 4 =
strong agree); a decision aid must have a score of 3 or
higher on each certification criterion to reach certifica-
tion standards. Finally, a large group of criteria were
identified as “quality criteria”, and included those items
that were not essential for reducing harms to patients
when using decision aids. No threshold is offered for
the quality criteria, which are scored on the same 1-4
scale.
2011-2013: Updating the evidence underlying the IPDAS
checklist
In 2009, the IPDAS Collaboration argued that new concepts
and empirical evidence had accumulated since 2005, and
consequently there was a need to update the 2005 Original
IPDAS Background Document. The IPDAS Background
Document Updating Group was charged with this effort.
Strategy
The IPDAS Background Document Updating Group con-
sisted of 12 chapter-writing teams (i.e., one team for each
of the original 12 quality dimensions). Volunteers who
were interested in serving as team leaders, co-leaders,
and/or members were identified using several strategies.
These included postings on the listserves “Shared-L” and
“SMDM-L”, advertisement at the 2009 International
Shared Decision Making Conference in Boston, Massa-
chusetts, review of the roster of participants on the 2005
Original IPDAS Background Document, and informal
networking among the participants.
Each chapter-writing team leader was identified from
senior individuals who had indicated an interest in ser-
ving as a team leader, and had conducted relevant
research in the area addressed by the specific chapter.
Each confirmed team leader was provided with: a) an
outline of the updating processes (see below) that their
team should follow; b) lists of the names of potential co-
leaders and team members who had volunteered through
the recruitment strategies described above; and c) the
names and contact information of any individuals—
including any of those who had co-authored the original
2005 Background Document chapters—who had not
directly volunteered but were experts in the field and
who might be interested in being involved.
Team leaders selected their co-leaders, and then
together the leaders and co-leaders selected the members
for their teams. In doing so, they were instructed to con-
sider the diversity of their team (e.g., a mix of basic scien-
tists, decision aid developers, and clinicians), and the
importance of international representation on the teams.
Final decisions about team membership were made by the
individual leaders and co-leaders. Taken together, these
teams involved 92 co-authors from 9 countries.
Updating processes
Each of the 12 chapter-writing teams was charged with
creating an updated chapter consisting of 7 major
sections:
1. Current authors and affiliations
2. A chapter summary
3. An updated definition (conceptual/operational) of
the quality dimension
4. An updated theoretical rationale for inclusion of the
quality dimension
5. An updated evidence base underlying the quality
dimension
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6. Updated references
7. Appendices, including supporting materials (if
needed), and the relevant 2005 Original Background
Document Chapter.
Sections 3, 4, and 5 required the most work on the
part of a writing team. Within each of these sections, a
team’s search, retrieval, and appraisal of the relevant
theoretical and empirical literature focused primarily on:
a) high-quality publications that are squarely in the field
of patients’ decision aids / patients’ decision making; and
b) high-quality publications that are clearly in the larger
field of health care in general. Within each of these sec-
tions, a team could also identify particularly important
relevant publications in other non-health-related fields
(e.g., psychology, business, adult education); the points
raised by these publications could then be outlined in
the “emerging issues / future research” sub-sections of
the new chapter in the updated Background Document.
Each team followed established writing guidelines and
used a common writing format, as they considered,
summarized, and presented the theoretical and eviden-
tiary literature relevant to the quality dimension
addressed by their chapter. However, each writing team
necessarily worked out its own procedures for dividing
up the team’s work, circulating initial drafts among its
members, resolving points of discussion via e-mail and/
or conference call, and preparing the final submitted
version of their updated chapter.
These updating efforts resulted in the IPDAS Colla-
boration’s new 12-chapter “2012 Updated Background
Document” [1]; it can be found at the IPDAS collabora-
tion website (http://ipdas.ohri.ca/resources.html).
This set of manuscripts
This supplement to BMC Medical Informatics and Deci-
sion Making builds on the work reported in the 2012
Updated Background Document. Here, a set of 12 manu-
scripts report—in greater depth than was possible in the
2012 Updated Background Document—the relevant defi-
nitions, theoretical justifications, conceptual arguments,
evidence-base, and emerging issues relevant to each of the
IPDAS Collaboration’s quality standards. A thirteenth
manuscript moves beyond the mandate of the 2012
Updated Background Document, and addresses the cur-
rent challenges inherent in efforts to introduce patient
decision aids into routine clinical practice. A total of 102
authors from 10 countries participated in writing these
manuscripts. All manuscripts were peer-reviewed as part
of the publication process.
Manuscript highlights
• Angela Coulter and colleagues observe that publica-
tions about patient decision aids provide limited detailed
information about the processes by which the aids are
developed [12]. They present a comprehensive model of
the development process, including specific phases of
development and a template for reporting key elements
in the development process.
• A team led by Michael Barry addresses the issue of dis-
closing conflicts of interest, emphasizing that disclosures
be reported prominently and in plain language [13]. In
addition to reporting sources of funding for development
and distribution, and whether funders, authors, or their
affiliations stand to gain or lose by the choices made by
patients using the aids, they propose a third criterion
which substantially raises the bar for developers and distri-
butors of patient decision aids. They argue that no funding
for the development or exclusive distribution of the deci-
sion aid be received from commercial, for-profit entities
that stand to benefit from the tests or treatments included
as options in the aid.
• Deb Feldman-Stewart and colleagues offer a broad
definition of the kinds of information patients need to
make informed decisions using patient decision aids
[14]. They recommend that investigators drill down to
the details related to patients’ information needs and
use systematic quantitative study designs to identify the
prevalence and extent of variability in these needs.
• A team led by Victor Montori expands the previous
chapter on using up-to-date scientific evidence to
include evidence that is comprehensive and critically
appraised [15]. They further note the importance of
communicating the degree of confidence in the evi-
dence, drawing on the approach used by Grading of
Recommendations Assessment, Development and Eva-
luation (GRADE) system.
• Purva Abhyankar and colleagues address the challen-
ging issue of balancing the presentation of information
and options in patient decision aids [16]. They provide
evidence supporting the use of side-by-side presentation
formats for the information about the options being pre-
sented in a patient decision aid. They also raise the pro-
vocative question of whether patient decision aids
should ever be used to nudge patients toward certain
options.
• Lyndal Trevena, Brian Zikmund-Fisher and collea-
gues move beyond the background document on com-
municating probabilities to summarize the state of the
science in presenting quantitative information about
decision outcomes in patient decision aids [17]. In doing
so, they have developed a risk communication primer
for decision aid developers, and a major resource for the
field in general, addressing 11 key issues when present-
ing quantitative information.
• Theoretical and methodological issues in the use of
values clarification methods in patient decision aids are
addressed by the team headed by Angela Fagerlin and
Michael Pignone [18]. This group argues that values
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clarification methods can focus on attributes of options,
options as whole entities, and the decision context.
They further note a number of promising decision mak-
ing theories that could be used to guide design and eva-
luation of values clarification methods.
• Hilary Bekker heads a group of investigators consid-
ering the role of personal stories in patient decision
aids, addressing the question about whether or not stor-
ies make aids more effective [19]. They emphasize that
developers should be explicit about the purpose of
patient stories in their aids and that the field could ben-
efit from a taxonomy of stories in decision aids. They
further note the tremendous scope for research on the
role of stories in decision making and behavioral change,
including identifying active components of stories and
how they facilitate or bias decision making.
• A team headed by Kirsten McCaffery and Stacey
Sheridan tackle the rapidly evolving field of health lit-
eracy, noting new definitions that recognize multiple
levels of health literacy beyond reading comprehension
[20]. They note that patient decision aids are rarely
developed with lower literacy populations in mind, and
measures of health literacy and readability of patient
decision aids are rarely reported. They further identify
specific research gaps in the field (e.g., the role of health
literacy in the process of values clarification) to guide
patient decision aid developers.
• Dawn Stacey and colleagues review theoretical and
empirical developments related to guidance (i.e., explicit
elements in patient decision aids that facilitate self-
directed decision making) and coaching (i.e., the use of
trained individuals who support decision making) with
patient decision aids [21]. Among the randomized trials
they found that coaching provided with a patient deci-
sion aid was associated with improved outcomes; no
trials were available on elements of guidance. They
advocate for randomized trials to compare the effective-
ness of coaching used with and without decision aids,
and decision aids used with and without coaches.
• Constructs and measurement instruments for estab-
lishing the effectiveness of patient decision aids are
addressed by a team led by Karen Sepucha and Richard
Thomson [22]. They distinguish the quality of the deci-
sion-making process and the quality of the choice, and
find strong evidence that patient decision aids enhance
both process and quality decisions for patients. They
further note the need for consensus around standardized
measures for establishing the effectiveness of patient
decision aids.
• Aubri Hoffman heads a group looking at the rapidly
evolving field of patient decision aids delivered on the
Internet [23]. They identify different characteristics of
patient decision aids delivered on the Internet, ranging
from aids developed for other formats and placed on the
Internet to those specifically designed and tested for use
on the Internet. Currently, few randomized trials on
Internet-delivered patient decision aids have been con-
ducted, and this group offers a rich agenda for basic and
applied research in this area.
• The final manuscript is this supplement addresses
the challenges of implementing patient decision aids in
routine clinical settings. Elwyn and colleagues report the
findings from a systematic review about the implemen-
tation of patient decision aids (they use the term
“patient decision support interventions”) in clinical set-
tings, noting barriers related to implementation includ-
ing apparent indifference on the part of health care
professionals regarding use of these tools [24]. They
further acknowledge that it is too early to make firm
recommendations about best strategies for implementa-
tion of patient decision aids in routine clinical settings.
A note about funding
The IPDAS Collaboration’s 2012 Updated Background
Document was prepared without centralized financial
support. Individual chapter leads/co-leads/members
indirectly were supported by their affiliation sites while
they worked as volunteers on this project, and adminis-
trative support for the entire update process was pro-
vided as “gifts in kind”.
Furthermore, no centralized support was sought or
provided for creation of the manuscripts included in
this BMC Medical Informatics and Decision Making
supplement. The individuals involved in writing these
papers used a variety of funding sources, including
support from their institutions. The Informed Medical
Decisions Foundation supported publication of this
supplement by covering about half of the publication
fees.
In conclusion
This set of 13 manuscripts highlight a wide range of
fundamental and applied research issues that are highly
relevant to the creation, evaluation, and implementation
of patient decision aids. In the face of this multi-faceted
argument, there are differing opinions about which are
the most pressing research priorities in this field of
inquiry. We think that neither the “let’s-get-all-the-
basic-research-questions-dealt-with-before-we-go-any-
further” perspective nor the “we-know-enough-so-let’s-
put-all-our-resources-into-full-bore-implementation”
perspective is of greater importance. We think that, ulti-
mately, patients, practitioners, students, new investiga-
tors in the field, policy-makers, and health care leaders
will most benefit if both streams of investigations—
those motivated by fundamental questions and those
focusing on implementation problems—are able to pro-
ceed in parallel, in a collegial, interdisciplinary manner.
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